| Four-month clinical status of a cohort of patients after hospitalization for COVID-19 L Morin, L Savale, T Pham, R Colle, S Figueiredo, A Harrois, M Gasnier, ... Jama 325 (15), 1525-1534, 2021 | 567 | 2021 |
| Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound? M Gousseff, P Penot, L Gallay, D Batisse, N Benech, K Bouiller, ... Journal of Infection 81 (5), 816-846, 2020 | 350 | 2020 |
| High rate of acquisition but short duration of carriage of multidrug-resistant Enterobacteriaceae after travel to the tropics E Ruppé, L Armand-Lefèvre, C Estellat, PH Consigny, A El Mniai, ... Clinical Infectious Diseases 61 (4), 593-600, 2015 | 291 | 2015 |
| Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis F Lanternier, S Poiree, C Elie, D Garcia-Hermoso, P Bakouboula, ... Journal of Antimicrobial Chemotherapy 70 (11), 3116-3123, 2015 | 168 | 2015 |
| Vaccine education of medical students: a nationwide cross-sectional survey S Kernéis, C Jacquet, A Bannay, T May, O Launay, P Verger, C Pulcini, ... American journal of preventive medicine 53 (3), e97-e104, 2017 | 128 | 2017 |
| Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled … A Dinh, J Ropers, C Duran, B Davido, L Deconinck, M Matt, O Senard, ... The Lancet 397 (10280), 1195-1203, 2021 | 109 | 2021 |
| Analysis of Chlamydia caviae entry sites and involvement of Cdc42 and Rac activity A Subtil, B Wyplosz, ME Balañá, A Dautry-Varsat Journal of cell science 117 (17), 3923-3933, 2004 | 93 | 2004 |
| HIV-associated vascular diseases: structural and functional changes, clinical implications JJ Monsuez, JC Charniot, L Escaut, E Teicher, B Wyplosz, C Couzigou, ... International journal of cardiology 133 (3), 293-306, 2009 | 90 | 2009 |
| Agreement between erythrocyte sedimentation rate and C-reactive protein in hospital practice I Colombet, J Pouchot, V Kronz, X Hanras, L Capron, P Durieux, ... The American journal of medicine 123 (9), 863. e7-863. e13, 2010 | 85 | 2010 |
| Chlamydia– Host Cell Interactions: Recent Advances on Bacterial Entry and Intracellular Development A Dautry‐Varsat, ME Balañá, B Wyplosz Traffic 5 (8), 561-570, 2004 | 62 | 2004 |
| Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011–2013 S Jauréguiberry, M Thellier, PA Ndour, F Ader, C Roussel, R Sonneville, ... Emerging infectious diseases 21 (5), 804, 2015 | 59 | 2015 |
| Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation F Schlemmer, S Chevret, G Lorillon, C De Bazelaire, RP de Latour, ... Respiratory Medicine 108 (10), 1525-1533, 2014 | 52 | 2014 |
| Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort study S Kernéis, O Launay, T Ancelle, L Iordache, V Naneix‐Laroche, F Méchaï, ... Arthritis care & research 65 (9), 1522-1528, 2013 | 50 | 2013 |
| Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study V Prendki, T Ferry, P Sergent, E Oziol, E Forestier, T Fraisse, S Tounes, ... European Journal of Clinical Microbiology & Infectious Diseases 36, 1577-1585, 2017 | 48 | 2017 |
| Use of ceftolozane/tazobactam as salvage therapy for infections due to extensively drug-resistant Pseudomonas aeruginosa A Dinh, B Wyplosz, S Kernéis, D Lebeaux, F Bouchand, C Duran, ... International journal of antimicrobial agents 49 (6), 782-783, 2017 | 41 | 2017 |
| Imported tickborne relapsing fever, France B Wyplosz, L Mihaila-Amrouche, MT Baixench, ML Bigel, ... Emerging infectious diseases 11 (11), 1801, 2005 | 41 | 2005 |
| Persistence of yellow fever vaccine–induced antibodies after solid organ transplantation B Wyplosz, C Burdet, H Francois, A Durrbach, JC Duclos‐Vallée, ... American Journal of Transplantation 13 (9), 2458-2461, 2013 | 40 | 2013 |
| Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phylogenetic subgroup D2 O102-ST405 clone L Mihaila, B Wyplosz, O Clermont, L Garry, MC Hipeaux, D Vittecoq, ... Journal of antimicrobial chemotherapy 65 (7), 1537-1539, 2010 | 35 | 2010 |
| Susceptibility testing is key for the success of cefiderocol treatment: a retrospective cohort study A Bleibtreu, L Dortet, RA Bonnin, B Wyplosz, SC Sacleux, L Mihaila, ... Microorganisms 9 (2), 282, 2021 | 28 | 2021 |
| Sarcoidosis: an unusual cause of acute pericarditis B Wyplosz, E Marijon, J Dougados, J Pouchot Acta cardiologica 65 (1), 83-84, 2010 | 27 | 2010 |
Didier SamuelAP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, F-94800, France ; Univ Paris-Sud, UMR-S 785, Villejuif, F-94800Verified email at pbr.aphp.fr
